AI

  • 3D body scanner and AI help predict metabolic syndrome risk

    Researchers at Mayo Clinic are using artificial intelligence (AI) with an advanced 3D body-volume scanner – originally developed for the clothing industry – to help doctors predict metabolic syndrome risk and severity. The combination of tools offers doctors a more precise alternative to other measures of disease risk like body mass index (BMI) and waist-to-hip [...]

  • Ruling out abnormal pathology on chest X-rays with AI

    A new study has shown that a commercial artificial intelligence (AI) tool used off-label was effective at excluding pathology and had equal or lower rates of critical misses on chest X-ray than radiologists. Recent developments in AI have sparked a growing interest in computer-assisted diagnosis, partly motivated by the increasing workload faced by radiology departments, [...]

  • Large language models cannot learn independently or acquire new skills

    A new study from the University of Bath and the Technical University of Darmstadt in Germany has found that large language models (LLMs) cannot learn independently or acquire new skills, meaning they pose no existential threat to humanity. The study found that LLMs have a superficial ability to follow instructions and excel at proficiency in [...]

  • AI drug discovery companies Recursion and Exscientia to merge

    Recursion and Exscientia plc have announced that the two companies have entered into a definitive agreement, combining Recursion, a clinical stage technology-enabled biotech company decoding biology to industrialise drug discovery, with Exscientia, a technology-driven clinical stage drug design and development company, committed to creating more effective medicines for patients, faster. Once integrated, the companies believe [...]

  • Report calls for more human oversight of GenAI

    Most consumers want businesses to employ human oversight and establish guardrails for the use of generative AI (GenAI) tools like ChatGPT, new research has found. Smart Communications’ research, which surveyed 2000 consumers worldwide regarding their opinions on customer communications from financial services, insurance and healthcare companies, shows that Over three-quarters (77 per cent) of consumers [...]

  • AI outperforms clinical tests at predicting Alzheimer’s progress

    Researchers at the University of Cambridge have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease. The team say this new approach could reduce the need for invasive and costly diagnostic tests while improving treatment outcomes early [...]

  • AI speeds up heart scans and could lead to better treatment

    Researchers have developed a new method for analysing heart MRI scans with the help of artificial intelligence (AI), which could save valuable NHS time and resources, as well as improve care for patients.  The teams from the Universities of East Anglia (UEA), Sheffield and Leeds created an intelligent computer model that utilises AI to examine [...]

  • Deep learning model shows promise for diagnosing osteoporosis

    Osteoporosis is so difficult to detect in its early stages that it is dubbed the “silent disease.” Now, Tulane University researchers have developed a new deep learning algorithm that outperformed existing computer-based osteoporosis risk prediction methods, potentially leading to earlier diagnoses and better outcomes for patients with osteoporosis risk. Deep learning models have gained notice [...]

  • AI model could improve clinical trial recruitment for eye disease

    A team of UK researchers has developed a new artificial intelligence (AI) system that could significantly reduce the time and cost required to recruit clinical trial patients for an advanced form of age-related vision loss. The system focuses on Geographic Atrophy (GA), an advanced form of dry age-related macular degeneration (AMD) leading to irreversible vision [...]

  • AI enables faster, more effective antibiotic treatment of sepsis

    In a study presented at ASM Microbe, a team from Day Zero Diagnostics unveiled a novel approach to antimicrobial susceptibility testing using artificial intelligence (AI). Sepsis is a life-threatening infection complication and accounts for 1.7 million hospitalisations and 350,000 deaths annually in the U.S. Fast and accurate diagnosis is critical, as mortality risk increases up [...]